Unknown

Dataset Information

0

Antagonizing the renin-angiotensin-aldosterone system in the era of COVID-19.

ABSTRACT:

SUBMITTER: Sarzani R 

PROVIDER: S-EPMC7233190 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Antagonizing the renin-angiotensin-aldosterone system in the era of COVID-19.

Sarzani Riccardo R   Giulietti Federico F   Di Pentima Chiara C   Filipponi Andrea A   Spannella Francesco F  

Internal and emergency medicine 20200518 5

Similar Datasets

Unknown COVID-19 and renin angiotensin aldosterone system: Pathogenesis and therapy.
| S-EPMC8596942 | biostudies-literature
Unknown Inhibitors of the Renin-Angiotensin-Aldosterone System and Covid-19.
| S-EPMC7224604 | biostudies-literature
Unknown Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19.
| S-EPMC7206932 | biostudies-literature
Unknown Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.
| S-EPMC7121452 | biostudies-literature
Unknown Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19.
| S-EPMC7206933 | biostudies-literature
Unknown Renin-Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID-19.
| S-EPMC8475700 | biostudies-literature
Unknown Renin-Angiotensin-Aldosterone Inhibitors and COVID-19 Infection.
| S-EPMC9206216 | biostudies-literature
Unknown Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System.
| S-EPMC7555368 | biostudies-literature
Unknown Potential use of renin-angiotensin-aldosterone system inhibitors to reduce COVID-19 severity.
| S-EPMC9999244 | biostudies-literature
Unknown Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.
| S-EPMC8237039 | biostudies-literature